FDA
approval
· 2023-06-28
FDA Approved: CABERGOLINE — Supplemental Application (Teva Pharmaceuticals USA, Inc.)
Summary
The FDA approved Teva Pharmaceuticals USA, Inc.'s supplemental application for cabergoline.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
SUPPL AP for CABERGOLINE (CABERGOLINE)